TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT06117605

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Nurse SIRS alert
Description: An electronic alert will display when a nurse opens the patient chart of a patient who meets SIRS criteria.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Nurse SIRS alert
Description: An electronic alert will display when a nurse opens the patient chart of a patient who meets SIRS criteria.
Study: NCT05909995

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: INCB 99280 with Ipilimumab
Description: Dose Escalation and expansion of INCB 99280 with Ipilimumab

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: INCB 99280 with Ipilimumab
Description: Dose Escalation and expansion of INCB 99280 with Ipilimumab
Study: NCT06117605

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Prescribing clinician SIRS alert
Description: An electronic alert will display when a prescribing clinician opens the patient chart of a patient who meets SIRS criteria.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Prescribing clinician SIRS alert
Description: An electronic alert will display when a prescribing clinician opens the patient chart of a patient who meets SIRS criteria.
Study: NCT06133179

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Transtemporal ultrasound with contrast product (Sonovue)
Description: During their hospitalization and in the 7 days following their stroke, all patients will perform a transtemporal ultrasound including the use of Sonovue contrast product.~The examination will last 1 hour and will be carried out on the opposite side of the stroke then on the side of the stroke
Study: NCT06067802

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Triheptanoin
Description: Open-label design with doses of triheptanoin up to 1.0 gm/kg triheptanoin
Study: NCT06521125

Intervention type: DIAGNOSTIC_TEST
Intervention: High resolution Computed Tomography (HRCT) scans of the Chest
Description: A chest high-resolution computed tomography (HRCT) scan will be performed

Intervention type: DIAGNOSTIC_TEST
Intervention: High resolution Computed Tomography (HRCT) scans of the Chest
Description: A chest high-resolution computed tomography (HRCT) scan will be performed

Intervention type: DIAGNOSTIC_TEST
Intervention: Pulmonary Function Testing (PFTs)
Description: Spirometry and diffusing capacity of the lung for carbon monoxide (DLCO) measurements will be performed

Intervention type: DIAGNOSTIC_TEST
Intervention: Pulmonary Function Testing (PFTs)
Description: Spirometry and diffusing capacity of the lung for carbon monoxide (DLCO) measurements will be performed

Intervention type: DIAGNOSTIC_TEST
Intervention: Digital lung sounds auscultation
Description: Lung sounds will be recorded using a manual approach with a digital stethoscope

Intervention type: DIAGNOSTIC_TEST
Intervention: Digital lung sounds auscultation
Description: Lung sounds will be recorded using a manual approach with a digital stethoscope

Intervention type: DIAGNOSTIC_TEST
Intervention: Laboratory Assessments
Description: Clinical laboratory tests will be collected from each participant

Intervention type: DIAGNOSTIC_TEST
Intervention: Laboratory Assessments
Description: Clinical laboratory tests will be collected from each participant

Intervention type: GENETIC
Intervention: DNA sequencing
Description: A sample of genomic DNA from peripheral blood lymphocytes will be collected for DNA sequencing

Intervention type: GENETIC
Intervention: DNA sequencing
Description: A sample of genomic DNA from peripheral blood lymphocytes will be collected for DNA sequencing
Study: NCT06204757

Intervention type: OTHER
Intervention: questionary
Description: questionary relating to birth trauma are completed by midwives and patients

Intervention type: OTHER
Intervention: questionary
Description: questionary relating to birth trauma are completed by midwives and patients
Study: NCT04327154

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: TISSIUM™ Nerve Coaptation Device
Description: Placement of the TISSIUM™ Nerve Coaptation Device on repair site to achieve an end-to-end nerve coaptation.
Study: NCT06061809

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bevacizumab
Description: Participants will receive 10mg/kg of Bevacizumab intravenously (IV) on Day 1 and Day 15 of each repeated cycle of treatment.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PD-L1 t-haNK
Description: Participants will receive PD-L1 t-haNK (\~2 × 109 cells/infusion) intravenously (IV) on Day 1 and Day 15 of each repeated cycle of treatment.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: N-803
Description: Participants will receive 1mg subcutaneously (SC) on Day 1 and Day 15 of each repeated cycle of treatment.
Study: NCT04673643

Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Transcutaneous Auricular Vagus Nerve Stimulation
Description: taVNS device (Elmmedicare, EC100, Shenzhen, China) was used to apply stimulation for patients.~Stimulation parameters comprised an electrical current of 1 mA at a frequency of 20 Hz, with a waveform width of 1 ms. Repurposed off-the-shelf devices were utilized for this purpose, with the stimulator generating single square-wave pulses lasting 1 ms each. Enhancing conductivity was achieved by wiping the ear with tap water. The electrodes were placed on the cymba conchae and concha around the affected ear, which is the region of rich vagus nerve branch distribution. Patients in control group were applied using the same stimulator, stimulation parameters and same sessions. However, the electrodes were placed on the antihelix around the affected ear, which is the region of few vagus nerve branch distribution.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcutaneous Auricular Vagus Nerve Stimulation
Description: taVNS device (Elmmedicare, EC100, Shenzhen, China) was used to apply stimulation for patients.~Stimulation parameters comprised an electrical current of 1 mA at a frequency of 20 Hz, with a waveform width of 1 ms. Repurposed off-the-shelf devices were utilized for this purpose, with the stimulator generating single square-wave pulses lasting 1 ms each. Enhancing conductivity was achieved by wiping the ear with tap water. The electrodes were placed on the cymba conchae and concha around the affected ear, which is the region of rich vagus nerve branch distribution. Patients in control group were applied using the same stimulator, stimulation parameters and same sessions. However, the electrodes were placed on the antihelix around the affected ear, which is the region of few vagus nerve branch distribution.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Hyaluronic acid eye drops
Description: Participants in both groups received hyaluronic acid eye drops (HYLO COMOD® eye drops, Ursapharm, Ltd., Germany) with the treatment of 3 times a day.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Hyaluronic acid eye drops
Description: Participants in both groups received hyaluronic acid eye drops (HYLO COMOD® eye drops, Ursapharm, Ltd., Germany) with the treatment of 3 times a day.
Study: NCT05222451

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: DGA Diet
Description: A fully provisioned isocaloric, isonitrogenous study diet following the Dietary Guidelines for Americans (DGA)~Including:~* A variety of vegetables and fruits~* Grains, at least half of which are whole grains~* Fat-free or low-fat dairy~* A variety of protein foods, including seafood, lean meats and poultry, eggs, legumes, nuts, and seeds~* This healthy eating pattern also limits saturated fats and trans fats, added sugars, and sodium.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: MCT Diet
Description: A fully provisioned isocaloric, isonitrogenous study diet following the Dietary Guidelines for Americans supplemented with medium chain triglycerides (MCT).

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: KETO Diet
Description: A fully provisioned isocaloric, isonitrogenous ketogenic study diet.
Study: NCT05961722

Intervention type: OTHER
Intervention: preoperative IV 0.9% saline 400 ml
Description: Group 1 will be infused with IV 0.9% saline 400 mL.

Intervention type: OTHER
Intervention: preoperative dextrose 5% 400 ml
Description: Group 2 will be infused with dextrose 5% Dekstroz 400 ml.

Intervention type: OTHER
Intervention: preoperative and intraoperative dextrose 5% 400 ml
Description: Group 3 will be infused with dextrose preoperative 200 ml and intraoperative 200 ml 5% dextrose infusion.
Study: NCT02809235

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: coconut oil
Description: 3 tablespoons per day of supplemental coconut oil
Study: NCT05562999

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Rocuronium Bromide
Description: Moderate NMB (TOF 1-2)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rocuronium Bromide
Description: Deep NMB (PTC 1-2)
Study: NCT05205031

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Intraosseous access
Description: Needle placed in the bone marrow.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Intravenous
Description: Needle placed in a vein.
Study: NCT03708900

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LCI699
Description: osilodrostat (LCI699) is in the form of tablets for oral administration and comes in the following tablet strengths: 1 milligram (mg), 5 mg, and 10mg.
Study: NCT06119048

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: L-Phenylalanine
Description: 100 mg/kg
Study: NCT06655857

Intervention type: OTHER
Group type: OTHER
Intervention: Usual Care
Description: Participants are provided care as usual. Clinicians (CKD, HD, KTx) will educate participants on the kidney transplant process. Clinician will receive the education intervention to provide participants at study end.

Intervention type: OTHER
Group type: OTHER
Intervention: Community Health Worker Assistance
Description: Community health worker will address unmet social needs and participant symptoms through evaluations and intake to clinical and community services

Intervention type: OTHER
Group type: OTHER
Intervention: Community Health Worker Assistance
Description: Community health worker will address unmet social needs and participant symptoms through evaluations and intake to clinical and community services

Intervention type: OTHER
Group type: OTHER
Intervention: Intervention Providers
Description: Intervention providers will receive education, which will include training on working with CHWs, reducing bias in clinical decision-making, and increasing affirming/reducing stigmatizing language in electronic health records (EHRs).

Intervention type: OTHER
Group type: OTHER
Intervention: Intervention Providers
Description: Intervention providers will receive education, which will include training on working with CHWs, reducing bias in clinical decision-making, and increasing affirming/reducing stigmatizing language in electronic health records (EHRs).
Study: NCT06655168

Intervention type: DEVICE
Group type: OTHER
Intervention: Video Laryngoscopy
Description: orotracheal intubation by C-Mac ( Video laryngoscopy)

Intervention type: DEVICE
Group type: OTHER
Intervention: Direct Laryngoscopy
Description: Orotracheal intubation using Direct Laryngoscopy
Study: NCT06654687

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Transthoracic Echocardiography
Description: Transthoracic Echocardiography will be used to measure the changes in stroke volume and cardiac output.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Transthoracic Echocardiography
Description: Transthoracic Echocardiography will be used to measure the changes in stroke volume and cardiac output.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ringer lactate 1000 ml
Description: Patients will receive 1000 mL of Ringer's lactate solution over 15 minutes.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Albumin
Description: Patients will receive 250 mL of human albumin 5% over 10 minutes

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ringer lactate 750 ml
Description: Patients will receive 750 mL of Ringer's lactate solution over 15 minutes.
Study: NCT06503874

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Attention Training
Description: The APT-3 is an evidence-based, standardized computer-based training program that was designed to improve attention skills that underlie higher level cognitive processes (e.g., executive functions and memory).

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Music Group
Description: This group will listen to a pre-determined playlist of music following the same dosing as the attention training group as stated in the arms.
Study: NCT06595446

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Early Stent removal
Description: Ureteral JJ stents removed 5-7 days after radical cystectomy and ileal conduit formation

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Late Stent removal
Description: Ureteral JJ stents removed 4-6 weeks after radical cystectomy and ileal conduit formation
Study: NCT06602713

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Questionnaires
Description: Western Ontario Shoulder Instability questionnaire Western Ontario Rotator Cuff questionnaire Shoulder Instability Return to Sport after Injury questionnaire

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaires
Description: Western Ontario Shoulder Instability questionnaire Western Ontario Rotator Cuff questionnaire Shoulder Instability Return to Sport after Injury questionnaire

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Exercices
Description: isokinetic evaluation

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercices
Description: isokinetic evaluation
Study: NCT06594250

Intervention type: DIAGNOSTIC_TEST
Intervention: Nasal swab
Description: Nasal swab to detect nasal carriage of S. aureus

Intervention type: DIAGNOSTIC_TEST
Intervention: Nasal swab
Description: Nasal swab to detect nasal carriage of S. aureus

Intervention type: BIOLOGICAL
Intervention: Venous sampling
Description: Peripheral venous sampling to collect peripheral blood mononuclear cells.

Intervention type: BIOLOGICAL
Intervention: Venous sampling
Description: Peripheral venous sampling to collect peripheral blood mononuclear cells.

Intervention type: BIOLOGICAL
Intervention: Antibiotic treatment
Description: Antibiotic treatment for bacteremia (+/- 1 month), in all patients with S. aureus

Intervention type: BIOLOGICAL
Intervention: Antibiotic treatment
Description: Antibiotic treatment for bacteremia (+/- 1 month), in all patients with S. aureus

Intervention type: DEVICE
Intervention: Nasal swab
Description: A new nasal swab will be taken using the same technique, to see whether or not the carriage persists

Intervention type: DEVICE
Intervention: Nasal swab
Description: A new nasal swab will be taken using the same technique, to see whether or not the carriage persists

Intervention type: BIOLOGICAL
Intervention: Intracellular reservoir test
Description: In the event of positive carriage, a new intracellular reservoir test will be performed. A search for relapse (new S. aureus infection) or recurrence (S. aureus bacteremia if the 1st bacteremia was due to another pathogen) will be carried out.

Intervention type: BIOLOGICAL
Intervention: Intracellular reservoir test
Description: In the event of positive carriage, a new intracellular reservoir test will be performed. A search for relapse (new S. aureus infection) or recurrence (S. aureus bacteremia if the 1st bacteremia was due to another pathogen) will be carried out.
Study: NCT06593223

Intervention type: DEVICE
Intervention: Assess Non-invasive filling pressure(NIFP) in heart failure patients
Description: Assess Non-invasive filling pressure(NIFP) in outpatients with stable heart failure and inpatients with acute heart failure in ward

Intervention type: DEVICE
Intervention: Assess Non-invasive filling pressure(NIFP) in heart failure patients
Description: Assess Non-invasive filling pressure(NIFP) in outpatients with stable heart failure and inpatients with acute heart failure in ward
Study: NCT06597110

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: listened to ASMR
Description: ASMR refers to a physiological sensation triggered by specific auditory stimuli.ASMR, characterized by low-frequency human voice and ambient sounds, has garnered significant attention across social media platforms, short and long-form video platforms, and podcasts, owing to its unique pleasurable and stimulating effects. listen to ASMR for 10mins.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: listened to ASMR
Description: ASMR refers to a physiological sensation triggered by specific auditory stimuli.ASMR, characterized by low-frequency human voice and ambient sounds, has garnered significant attention across social media platforms, short and long-form video platforms, and podcasts, owing to its unique pleasurable and stimulating effects. listen to ASMR for 10mins.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: listened to ASMR
Description: ASMR refers to a physiological sensation triggered by specific auditory stimuli.ASMR, characterized by low-frequency human voice and ambient sounds, has garnered significant attention across social media platforms, short and long-form video platforms, and podcasts, owing to its unique pleasurable and stimulating effects. listen to ASMR for 10mins.
Study: NCT06595485

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: online mindfulness based intervention
Description: We anticipate the online MBI to be 10-20 minutes once daily, at least 5 days per week, for 8 weeks. Online MBI will be available free of charge on iOS and Android platforms. Participants will be instructed to download the app and use for practices. The online MBI group will be introduced to practice including mindful breathing (simple attention to the flow of the breath, inhalations, and exhalations), body scan (attention and awareness of different body parts) and practice of non-judgement of thoughts and emotions and guided meditation (sitting meditation). In addition, we anticipate participants in MBI group will have a group discussion via skype, 30 minute a week for 8 weeks. Moreover, we anticipate participants in MBI group to record how they practice in each day (attendance) as home assignment using online MBI application. For the details of mindfulness practice, we will develop based on data from interview and focus group
Study: NCT06599398

Intervention type: OTHER
Intervention: Jeroen Pit Huis
Description: The JPH is a unique and innovative Transitional Care Unit (TCU) situated in close proximity of the AUMC. In this TCU, patients and their family reside in separate private home-like apartments. The families can stay while practising in, and adapting to, their new reality until they are ready to transition home. A multidisciplinary team of healthcare experts (nurses, psychosocial care workers, family counsellors, and paediatricians) are gradually guiding parents towards taking on the role of their child's primary caregiver. This process is guided by a newly developed seven phase care path.One condition for staying in the JPH is that one parent is always present. In this form (24/7 parental stay and nursing care directly available under the supervision of pediatricians) the JPH is unique in the Netherlands.

Intervention type: OTHER
Intervention: Jeroen Pit Huis
Description: The JPH is a unique and innovative Transitional Care Unit (TCU) situated in close proximity of the AUMC. In this TCU, patients and their family reside in separate private home-like apartments. The families can stay while practising in, and adapting to, their new reality until they are ready to transition home. A multidisciplinary team of healthcare experts (nurses, psychosocial care workers, family counsellors, and paediatricians) are gradually guiding parents towards taking on the role of their child's primary caregiver. This process is guided by a newly developed seven phase care path.One condition for staying in the JPH is that one parent is always present. In this form (24/7 parental stay and nursing care directly available under the supervision of pediatricians) the JPH is unique in the Netherlands.
Study: NCT06603740

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Arthrex Nanoscope
Description: Arthrex's all-in-one disposable, 2 mm, chip-on-tip camera system now allows surgeons to miniaturize their treatment solutions

Intervention type: DEVICE
Group type: OTHER
Intervention: Conventional Arthroscopy without Arthrex Nanoscope
Description: partial meniscectomy using conventional arthroscopy
Study: NCT06586099

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Aza, tislelizumab
Description: combination chemotherapy for the refractory/relapsed AML
Study: NCT06595732

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Pelvic floor and abdominal training
Description: Participants in this group will undergo 12 weeks of in-person training, with supervision by a specialist physical therapist, in groups of up to four women. The training will take place after an initial evaluation and will consist of 24 sessions, held twice a week. Exercises will target both the pelvic floor muscles and the abdominal muscles. The exercises will be divided into three phases, with progressively increasing difficulty each month. The progression will be achieved by increasing the load, the number of repetitions, and the complexity of the exercises.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Abdominal Hypopressive Technique Exercises
Description: Participants in this group will perform Hypopressive Abdominal Gymnastics exercises as proposed by Marcel Caufriez (1997). The training will last 12 weeks and be conducted in person, with supervision by a specialist physical therapist, in groups of up to four women. The training will take place after an initial evaluation and will consist of 24 sessions, held twice a week. The exercises will be divided into three phases, with progressively increasing difficulty each month. Progression will be achieved by changing body positions, increasing the number of repetitions, and extending the duration of inspiratory apnea.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Pelvic floor muscle training
Description: Participants in this group will undergo 12 weeks of in-person training, supervised by a specialist physical therapist, in groups of up to four women. Specific exercises targeting the pelvic floor muscles will be performed, with voluntary and maximal contractions, without involving other muscle groups. The exercises will be divided into three phases, with progressively increasing difficulty each month. Progression will be achieved by increasing the load (transitioning from gravitational to antigravitational positions), increasing the number of repetitions, and combining sustained and rapid contractions to enhance the difficulty of execution.
Study: NCT06597253

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Lactate sensor
Description: Continuous interstitial fluid lactate monitoring using the non-invasive Nemaura Investigational Lactate Device.
Study: NCT06588764

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: modified deep lateral and/or medial wall decompression
Description: Modified deep lateral orbital wall decompression is based on traditional outer wall decompression with combined abrasion of the deep outer orbital wall (including the greater pterygoid wing) to achieve adequate enlargement of the orbital cavity.